Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment
A benign circle: how a combination of factors has reduced HIV infections in one of the hardest-hit parts of Africa
Men from Latin America and central Europe now outnumber sub-Saharan Africans in HIV diagnoses in European migrants
Across western Europe, migrants from all parts of the world start HIV treatment later
Living with diagnosed HIV infection for a long time is associated with poor quality of life
NAM endorses Undetectable equals Untransmittable (U=U) consensus statement
